IDEX's Q4 Earnings Call: Our Top 5 Analyst Questions

IDEX’s fourth quarter was marked by a positive market reaction, as management pointed to strong order momentum in its Health, Science, and Technology (HST) segment and continued expansion in key verticals like data centers and semiconductors. CEO Eric Ashleman highlighted the company’s ability to leverage its cross-business capabilities, noting, “Our performance pneumatics group is helping customers support data center construction driven by demand from artificial intelligence.” Margin expansion was also attributed to the company’s disciplined application of its 8020 operational strategy and focused cost containment.

Is now the time to buy IEX? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From IDEX’s Q4 Earnings Call

• Deane Dray (RBC Capital Markets) asked about the lack of inflection in short-cycle industrial businesses despite improving macro indicators. CEO Eric Ashleman replied that order rates remain steady but have not shown significant upward movement, and the company is poised to react quickly if growth materializes.
• Vladimir Bystricky (Citigroup) requested details on price contribution versus volume in the growth outlook. CFO Sean Gillen explained that price was the primary driver in 2025, but expects a lower price contribution and flattish volumes across most segments in 2026.
• Michael Halloran (Baird) questioned the disconnect between strong HST orders and revenue conversion. Ashleman clarified that timing differences, especially in larger or fiscal-year-end orders, can delay revenue recognition but expects these to convert in coming quarters.
• Joseph Giordano (TD Cowen) inquired about the scale and capital intensity of the data center business. Ashleman responded that capital requirements are modest, with growth driven by higher output of existing products and minimal new equipment needed.
• Matt Summerville (D.A. Davidson) sought clarification on the sustainability of HST order momentum and further cost optimization opportunities. Ashleman confirmed ongoing order strength in January and Gillen indicated most cost savings were realized in 2025, with only minor incremental benefits expected in 2026.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will watch for (1) sustained order momentum and revenue conversion in the HST segment, especially from data center and semiconductor markets; (2) any signs of stabilization or recovery in industrial, chemical, and agricultural demand, which could provide incremental upside; and (3) progress integrating bolt-on acquisitions like Microlam and their impact on portfolio growth. The company’s capital allocation toward high-return investments and share repurchases also remains a key area of focus.

IDEX currently trades at $214.58, up from $201.61 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.